Selective Regulation of Bone Cell Apoptosis by Translational Isoforms of the Glucocorticoid Receptor
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are widely used in the treatment of inflammatory and other diseases. However, high-dose or chronic administration often triggers troublesome side effects such as metabolic syndrome and osteoporosis. We recently described that one glucocorticoid receptor gene produces eight translational glucocorticoid receptor isoforms that have distinct gene-regulatory abilities. We show here that specific, but not all, glucocorticoid receptor isoforms induced apoptosis in human osteosarcoma U-2 OS bone cells. Whole human genome microarray analysis revealed that the majority of the glucocorticoid target genes were selectively regulated by specific glucocorticoid receptor isoforms. Real-time PCR experiments confirmed that proapoptotic enzymes necessary for cell death, granzyme A and caspase-6, were induced by specific glucocorticoid receptor isoforms. Chromatin immunoprecipitation assays further suggested that glucocorticoid receptor isoform-dependent induction of proapoptotic genes was likely due to selective coregulator recruitment and chromatin modification. Interestingly, the capabilities to transrepress proinflammatory genes were similar among glucocorticoid receptor isoforms. Together, these findings provide new evidence that translational glucocorticoid receptor isoforms can elicit distinct glucocorticoid responses and may be useful for the development of safe glucocorticoids with reduced side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When individual isoforms are expressed in U2OS osteosarcoma or Jurkat T lymphoblastic leukemia cells, they each regulate a unique set of genes, with less than 10% being commonly regulated by all the isoforms64, 65.”
From Corticosteroids (2016) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An interesting difference among the GRα isoforms, is that each GR variant possesses a distinct transcription profile.”
From Corticosteroids (2016) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 1×
“gov/geo/) (7) and are accessible through Gene Expression Omnibus series ac-”
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Glucocorticoids are widely used in the clinic to treat a variety of diseases including inflammation, cancer, and autoimmune disorders (23).”
BackgroundSelf-citationMineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628 · cited 1×
“Although tissue-selective ligand availability and cofactor recruitment can partially explain the cell typeselective effects of glucocorticoids (1, 9, 11, 12), recent evidence suggests that tissue-selective expression of glucocorticoid receptor (GR) isoforms may also play a critical role in the tissue-selective respons…”
BackgroundScheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819 · cited 3×
“FIG. 7. GR isoforms differentially recruit cofactors onto the GZMA promoter region ( 27 ).”
BackgroundMethodSelf-citationO’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771 · cited 1×
“Studies of transgenic animals overexpressing 11- -hydroxysteroid dehydrogenase 2, an enzyme that reduces the active corticosteroid level, in osteoblasts and osteocytes suggest that glucocorticoids exert their cell-killing effects directly on bone cells (21).”
BackgroundCloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712 · cited 1×
“Although tissue-selective ligand availability and cofactor recruitment can partially explain the cell typeselective effects of glucocorticoids (1, 9, 11, 12), recent evidence suggests that tissue-selective expression of glucocorticoid receptor (GR) isoforms may also play a critical role in the tissue-selective respons…”
BackgroundLu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455 · cited 10×
“(18) were transfected into COS-1 cells using Transit LT1 reagent at 3 l per 1 g”
BackgroundMethodSelf-citationWallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394 · cited 1×
“2B), indicating that all GR isoforms are fully capable of undergoing ligand-dependent downregulation (31).”
BackgroundSelf-citationRosetta error model for gene expression analysis
Weng, L., Dai, H., Zhan, Y., He, Y., Stepaniants, S. B., & Bassett, D. E. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl045 · Cited by 305 · cited 1×
“This system performs data preprocessing and error modeling ( 33 ).”
Method
Cited by
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Self-citationThe biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“The GRα translational isoforms display a similar affinity for glucocorticoids and a similar capacity to interact with GREs following ligand activation; however, they show marked differences in other properties (8, 15).”
BackgroundSelf-citationRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationA General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
“In vitro work proved that these isoforms do have the capability to regulate distinct transcriptional programs (96).”
BackgroundSurjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551
Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I. M., & De Bosscher, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.014 · Cited by 411
“Interestingly, each one of these isoforms, retaining a functional ligand-binding capacity, has the potential to modulate transcriptional programs in a differential manner (Lu et al., 2007; Oakley and Cidlowski, 2011).”
BackgroundOakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Self-citationCritical Illness-Related Corticosteroid Insufficiency
Marik, P. E. (2009) · Chest · doi:10.1378/chest.08-1149 · Cited by 299
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Comprehensive Overview of the Structure and Regulation of the Glucocorticoid Receptor
Vandevyver, S., Dejager, L., & Libert, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1010 · Cited by 265
Vreugdenhil, E., Verissimo, C. S. L., Mariman, R., Kamphorst, J. T., Barbosa, J. S., Zweers, T., Champagne, D. L., Schouten, T., Meijer, O. C., Ron de Kloet, E., et al. (2009) · Endocrinology · doi:10.1210/en.2008-1335 · Cited by 259
Hartmann, K., Koenen, M., Schauer, S., Wittig-Blaich, S., Ahmad, M., Baschant, U., & Tuckermann, J. P. (2016) · Physiological Reviews · doi:10.1152/physrev.00011.2015 · Cited by 247
“Currently, overexpression studies of the different isoforms in human osteosarcoma cells (U2OS) have demonstrated selective functions in the context of gene regulation and induction of apoptosis (213).”
Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling
Revollo, J. R., & Cidlowski, J. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04986.x · Cited by 220
Self-citationProgesterone-Related Immune Modulation of Pregnancy and Labor
Shah, N. M., Lai, P. F., Imami, N., & Johnson, M. R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00198 · Cited by 217
“Much in the same way as PR, the nGR isoforms have varied tissue distribution and are responsible for regulating the expression of distinct genes (110).”
BackgroundGalliher‐Beckley, A. J., & Cidlowski, J. A. (2009) · IUBMB Life · doi:10.1002/iub.245 · Cited by 206
“The activation of GR by hormone results in a transcriptional alteration of nearly 20% of the human genome (33); therefore,”
BackgroundSelf-citationImmune regulation by glucocorticoids can be linked to cell type–dependent transcriptional responses
Franco, L. M., Gadkari, M., Howe, K. N., Sun, J., Kardava, L., Kumar, P., Kumari, S., Hu, Z., Fraser, I. D. C., Moir, S., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180595 · Cited by 194
“Some of these differences may be the result of variation in the levels of the type II isozyme of 11β-hydroxysteroid dehydrogenase (11βHSD2) or of the β isoform of the GR (GRβ) across cell types, both of which are known to decrease the overall sensitivity of cells to glucocorticoids (Funder et al., 1988; Lu et al., 200…”
BackgroundRegulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 181
“Considering that GRβ can inhibit GRα activity, the modulation of GRα/GRβ expression ratios may be an interesting approach to regulate GC sensitivity (42, 43).”
BackgroundGlucocorticoids and reproduction: Traffic control on the road to reproduction
Whirledge, S., & Cidlowski, J. A. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.02.005 · Cited by 178
Self-citationMolecular mechanisms regulating glucocorticoid sensitivity and resistance
Gross, K. L., Lu, N. Z., & Cidlowski, J. A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.001 · Cited by 180
“Expression of the more active GRα-C3 correlated with increased sensitivity to glucocorticoid-induced apoptosis, and expression of the relatively inactive GRα-D3 was associated with resistance to glucocorticoid-induced apoptosis (Lu et al., 2007).”
BackgroundSelf-citationTissue-specific glucocorticoid action: a family affair
Gross, K. L., & Cidlowski, J. A. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.07.009 · Cited by 180
“Interestingly, expression of the more active GRα-C3 correlated with increased sensitivity to glucocorticoid-induced apoptosis, and the relatively inactive GRα-D3 was associated with resistance to glucocorticoid-induced apoptosis [39].”
BackgroundSelf-citationGlucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells
Schlossmacher, G., Stevens, A., & White, A. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0135 · Cited by 157
“This is exemplified by high expression levels of the GR-C3 isoform in bone cells that is associated with high levels of Gc-induced apoptosis (Lu et al. 2007).”
BackgroundInfluentialGlucocorticoid receptors: finding the middle ground
Desmet, S. J., & De Bosscher, K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88886 · Cited by 147
Tissue-Specific Actions of Glucocorticoids on Apoptosis: A Double-Edged Sword
Gruver-Yates, A., & Cidlowski, J. (2013) · Cells · doi:10.3390/cells2020202 · Cited by 147
“These data also suggest that the relative proportion of specific GR isoforms in tissues and cells may influence their response to GC-induced apoptosis [5].”
BackgroundSelf-citationTranscriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more
Turner, J. D., Alt, S. R., Cao, L., Vernocchi, S., Trifonova, S. T., Battello, N., & Muller, C. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.037 · Cited by 172
Glucocorticoid-Induced Apoptosis of Healthy and Malignant Lymphocytes
Smith, L. K., & Cidlowski, J. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82001-1 · Cited by 144
“Conversely, the GRα-D isoform is the least transcriptionally active and unable to induce apoptosis in a stably overexpressing osteosarcoma cell line (Lu et al., 2007).”
BackgroundSelf-citationMechanisms of Glucocorticoid Action During Development
Busada, J. T., & Cidlowski, J. A. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.12.004 · Cited by 168
Self-citationGalliher-Beckley, A. J., Williams, J. G., Collins, J. B., & Cidlowski, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00808-08 · Cited by 136
Self-citationExploring the Molecular Mechanisms of Glucocorticoid Receptor Action from Sensitivity to Resistance
Ramamoorthy, S., & Cidlowski, J. A. (2013) · Endocrine Development · doi:10.1159/000342502 · Cited by 134
“These data suggest that the glucocorticoid-induced transcriptional response reflects the composite actions of GRα isoforms and that the specific intracellular pool of GRα subtypes may determine cellular sensitivity to glucocorticoids [26].”
BackgroundSelf-citationThe Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Selective Glucocorticoid Receptor modulators
Bosscher, K. D. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.027 · Cited by 145
Specificity and sensitivity of glucocorticoid signaling in health and disease
Cain, D. W., & Cidlowski, J. A. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.007 · Cited by 127
Self-citationThe Glucocorticoid Receptor in Cardiovascular Health and Disease
Liu, B., Zhang, T., Knight, J. K., & Goodwin, J. E. (2019) · Cells · doi:10.3390/cells8101227 · Cited by 149
“For instance, the GR-C isoform was demonstrated to confer an increased susceptibility to apoptosis in cell culture while the GR-D isoform resulted in a relative resistance to apoptosis under the same conditions [20].”
BackgroundGlucocorticoid signaling in the heart: A cardiomyocyte perspective
Oakley, R. H., & Cidlowski, J. A. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.03.009 · Cited by 135
“Nuclear GR binds directly to GREs and induces or represses the expression of target genes (46–48), which can comprise up to 10–20% of the human genome (29, 49, 50).”
BackgroundSelf-citationLi, H., Qian, W., Weng, X., Wu, Z., Li, H., Zhuang, Q., Feng, B., & Bian, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037030 · Cited by 113
“We demonstrated that dexamethasone treatment can increase apoptosis more than two fold, which was consistent with previous studies [11].”
BackgroundResultInfluentialStaab-Weijnitz, C. A., & Maser, E. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.013 · Cited by 122
Pathophysiology of Glucocorticoid Signaling
Vitellius, G., Trabado, S., Bouligand, J., Delemer, B., & Lombès, M. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.001 · Cited by 116
Saif, Z., Hodyl, N. A., Hobbs, E., Tuck, A. R., Butler, M. S., Osei-Kumah, A., & Clifton, V. L. (2014) · Placenta · doi:10.1016/j.placenta.2014.01.012 · Cited by 100
“Exons 2e9 can generate various isoforms of GR through alternative splicing [8e10] or through alternative initiation of translation [10,11] resulting in the expression of GRa, GRb, GRg, GRA and GR-P proteins.”
BackgroundGlucocorticoid receptor signaling in bone cells
Moutsatsou, P., Kassi, E. N., & Papavassiliou, A. G. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.005 · Cited by 158
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
Gado, M., Baschant, U., Hofbauer, L. C., & Henneicke, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835720 · Cited by 108
BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis
Banuelos, J., Shin, S. C., Cao, Y., Bochner, B. S., Morales‐Nebreda, L., Budinger, G. R. S., Zhou, L., Li, S., Xin, J. J., Lingen, M. W., et al. (2016) · Allergy · doi:10.1111/all.12840 · Cited by 88
“The GR gene produces several GR isoforms, which we have previously shown to have distinct abilities to induce apoptosis (19, 20, 25).”
BackgroundSelf-citationA gradient of glucocorticoid sensitivity among helper T cell cytokines
Banuelos, J., & Lu, N. Z. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.002 · Cited by 79
“Because these GR translational isoforms have distinct NTDs, they have different transcriptional activities [30–34].”
BackgroundSelf-citationBruscoli, S., Donato, V., Velardi, E., Sante, M. D., Migliorati, G., Donato, R., & Riccardi, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070136 · Cited by 88
Facchinello, N., Skobo, T., Meneghetti, G., Colletti, E., Dinarello, A., Tiso, N., Costa, R., Gioacchini, G., Carnevali, O., Argenton, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04535-6 · Cited by 82
“A, the classical full-length hGR protein 35,36 .”
Cao, Y., Bender, I. K., Konstantinidis, A. K., Shin, S. C., Jewell, C. M., Cidlowski, J. A., Schleimer, R. P., & Lu, N. Z. (2013) · Blood · doi:10.1182/blood-2012-05-432336 · Cited by 76
Self-citationEndocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 91
“Hypercortisolism leads to loss of both viability and differentiation capacity in osteogenic cells through induction of apoptosis and suppression of osteoblast differentiation (Lu et al., 2007; Rauch et al., 2010; Xia et al., 2010).”
BackgroundHuman but Not Mouse Adipogenesis Is Critically Dependent on LMO3
Lindroos, J., Husa, J., Mitterer, G., Haschemi, A., Rauscher, S., Haas, R., Gröger, M., Loewe, R., Kohrgruber, N., Schrögendorfer, K. F., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.020 · Cited by 72
“Of note, several of these LMO3-enriched genes are well known GC targets, such as inhibitor of growth family, member 2 (ING2), TBC1 domain family, member 2B (TBC1D2B), tumor necrosis factor (ligand) superfamily, member 10 (TNFSF10), C-X-C motif chemokine 5 (CXCL5), and ecto nucleotide pyrophosphatase/ phosphodiesterase…”
Saif, Z., Hodyl, N. A., Stark, M. J., Fuller, P. J., Cole, T., Lu, N., & Clifton, V. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.05.001 · Cited by 71
“Exons 2–9 can generate various isoforms of GR either through alternative splicing [21–23] or via alternative initiation of translation [23,24].”
BackgroundSelf-citationWu, I., Shin, S. C., Cao, Y., Bender, I. K., Jafari, N., Feng, G., Lin, S., Cidlowski, J. A., Schleimer, R. P., & Lu, N. Z. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.193 · Cited by 64
“The selective apoptosis-inducing activity of GR isoforms in Jurkat cells confirmed the observations made previously in two sets of osteoblast U-2 OS clones.(12)”
BackgroundMethodResultSelf-citationJewell, C. M., Scoltock, A. B., Hamel, B. L., Yudt, M. R., & Cidlowski, J. A. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1116 · Cited by 64
“glucocorticoid-induced apoptosis (28), thus making this”
BackgroundSelf-citationZanchi, N. E., Filho, M. A. D. S., Felitti, V., Nicastro, H., Lorenzeti, F. M., & Lancha, A. H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22141 · Cited by 62
“On the other hand, it has been postulated that high expression levels of the GR-a-C3 isoform in bone cells is associated with high levels of apoptosis that is induced by glucocorticoids (Lu et al., 2007).”
BackgroundGross, K. L., Oakley, R. H., Scoltock, A. B., Jewell, C. M., & Cidlowski, J. A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0051 · Cited by 56
Self-citationPrimary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update
Nicolaides, N. C., & Charmandari, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910839 · Cited by 58
“These isoforms have progressively shorter N-terminal domains and different properties in terms of subcellular localization, expression, and function [26,27].”
BackgroundNicolaides, N. C., & Charmandari, E. (2017) · Hormones · doi:10.14310/horm.2002.1728 · Cited by 52
Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 56
Self-citationChafin, C. B., Regna, N. L., Hammond, S. E., & Reilly, C. M. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.013 · Cited by 51
“GR induce pro-apoptotic protein activation, including granzyme A, caspase-6, Bim, Bid and Bad, while repressing anti-apoptotic proteins such as Bcl-2, Mcl-1, and Bcl-xL [24,25].”
BackgroundSoto-Rodríguez, S., López-Armas, G. D. C., Luquín, S., Ramos-Zúñiga, R., Jáuregui-Huerta, F., González-Pérez, Ó., & González-Castañeda, R. E. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00132 · Cited by 48
Compartment-Restricted Biotinylation Reveals Novel Features of Prion Protein Metabolism in Vivo
Emerman, A. B., Zhang, Z.-R., Chakrabarti, O., & Hegde, R. S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-09-0742 · Cited by 53
“Even seemingly artifactual minor truncated versions of Glucocorticoid receptor resulting from internal translation initiation seem to be physiologically relevant functional products in vivo (Lu and Cidlowski, 2005; Lu et al., 2007).”
BackgroundGlucocorticoid signaling and osteoarthritis
Savvidou, O. D., Milonaki, M., Goumenos, S. D., Flevas, D. A., Papagelopoulos, P. J., & Moutsatsou, P. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.11.001 · Cited by 50
Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies
Clarisse, D., Offner, F. C., & Bosscher, K. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188430 · Cited by 53
“These include GRα-A, GRα-B, GRα-C1/C2/C3 and GRα-D1/D2/D3 [196], which were shown to have divergent abilities to mediate GC-induced apoptosis in different cell line models [197,198].”
BackgroundClifton, V. L., Cuffe, J. S. M., Moritz, K. M., Cole, T. J., Fuller, P. J., Lu, N. Z., Kumar, S., Chong, S., & Saif, Z. (2016) · Placenta · doi:10.1016/j.placenta.2016.12.017 · Cited by 47
Self-citationBreton, J., Heydet, D., Starrs, L. M., Veldre, T., & Ghildyal, R. (2018) · Physiological Reports · doi:10.14814/phy2.13669 · Cited by 46
“In the absence of ligand, GR is primarily cytoplasmic; while following ligand binding, it translocates to the nucleus, where it induces or represses the transcription of specific target genes (Galon et al. 2002; Lu et al. 2007; Ren et al. 2012).”
BackgroundInfluentialAckerman, W. E., Buhimschi, I. A., Eidem, H. R., Rinker, D. C., Rokas, A., Rood, K. M., Zhao, G., Summerfield, T. L. S., Landon, M. B., & Buhimschi, C. S. (2016) · Placenta · doi:10.1016/j.placenta.2016.05.010 · Cited by 41
Turner, J. D., Vernocchi, S., Schmitz, S., & Muller, C. P. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.010 · Cited by 42
Spampinato, S. M., Baiula, M., Bedini, A., Baldi, J., Govoni, P., & Cavet, M. E. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s62659 · Cited by 43
“These isoforms have distinct tissue distribution patterns and are capable of regulating unique sets of genes and mediating glucocorticoid-induced apoptosis in distinct manners.(49) For instance, the glucocorticoid receptorC3 isoform induces the expression of proapoptotic molecules more efficiently than the D3 isoform.”
Camozzi, V., Betterle, C., Frigo, A. C., Zaccariotto, V., Zaninotto, M., Caneva, E. D., Lucato, P., Gomiero, W., Garelli, S., Sabbadin, C., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1380-8 · Cited by 39
Oakley, R. H., Ramamoorthy, S., Foley, J. F., Busada, J. T., Lu, N. Z., & Cidlowski, J. A. (2018) · The FASEB Journal · doi:10.1096/fj.201701153r · Cited by 37
Self-citationChantzichristos, D., Svensson, P.-A., Garner, T., Glad, C. A., Walker, B. R., Bergthorsdottir, R., Ragnarsson, O., Trimpou, P., Stimson, R. H., Borresen, S. W., et al. (2021) · eLife · doi:10.7554/elife.62236 · Cited by 36
“Osteosarcoma cell line response to activation of specific GC receptor alpha isoforms GSE6711 17682054 (Lu et al., 2007) 22174376 (Jewell et al.”
BackgroundUeno, K., Ninomiya, Y., Hazeki, D., Masuda, K., Nomura, Y., & Kawano, Y. (2017) · Scientific Reports · doi:10.1038/srep43719 · Cited by 36
Importance of glucocorticoid receptors in upper and lower airways
Pujols, L., Mullol, J., & Picado, C. (2009) · Frontiers in bioscience · doi:10.2741/3646 · Cited by 34
“It has recently been observed that all these GR alpha isoforms can elicit apoptosis of human bone cells (17).”
BackgroundKo, J., Wu, R., Kuo, S., Chen, M., Yeh, D., Ke, H., Wu, S., & Wang, F. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33457 · Cited by 32
Saif, Z., Dyson, R. M., Palliser, H. K., Wright, I. M. R., Lu, N. Z., & Clifton, V. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148226 · Cited by 32
“Exons 2–9 can generate various isoforms of GR through alternative splicing [15–17] or through alternative initiation of translation [17,18] resulting in the expression of GRα, GRβ, GRγ, GR-A and GR-P proteins.”
BackgroundSelf-citationWu, R., Lin, T.-P., Ko, J., Yeh, D., Chen, M.-W., Ke, H.-C., Wu, S.-L., & Wang, F. (2011) · Bone · doi:10.1016/j.bone.2011.08.022 · Cited by 30
“Intensive apoptotic reactions in osteoblasts or autophagic activities in osteocytes contribute to glucocorticoid-induced inhibition of bone cell viability [6–8].”
BackgroundJoshi, T., Johnson, M. W., Newton, R., & Giembycz, M. A. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13014 · Cited by 31
“In the analyses performed here, agonist affinity was assumed to be invariant across these different receptor subtypes, which is supported by available data (Lu and Cidlowski, 2005; Lu et al., 2007).”
BackgroundGlucocorticoid Receptor in Human Respiratory Epithelial Cells
Pujols, L., Mullol, J., & Picado, C. (2009) · NeuroImmunoModulation · doi:10.1159/000216187 · Cited by 31
“It has been recently found that all these GRα isoforms can elicit apoptosis of human bone cells [”
BackgroundMolecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies
Scheijen, B. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.29 · Cited by 41
“These phenotypes correlate with the gene regulatory profiles, where the GRa-C isoform is the most active in the ability to enhance transcription of GC-responsive reporter and endogenous genes([95,97]).”
BackgroundInfluentialOakley, R. H., Busillo, J. M., & Cidlowski, J. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.758888 · Cited by 32
Self-citationEffect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages.
Samir, S. M., & Malek, H. A. (2014) · PubMed · Cited by 32
Chen, K., Man, K., Metselaar, H. J., Janssen, H. L. A., Peppelenbosch, M. P., & Pan, Q. (2013) · Liver Transplantation · doi:10.1002/lt.23806 · Cited by 26
“As for the mechanism by which steroids trigger apoptosis, a series of studies have demonstrated that steroids can activate cell death through the induction of proapoptotic members of the B cell lymphoma 2 family(19,20) and the suppression of antiapoptotic members.(21,22) However, the responsiveness and the mechanisms…”
BackgroundSommer, P., Cowen, R. L., Berry, A. A., Cookson, A., Telfer, B. A., Williams, K. J., Stratford, I. J., Kay, P., White, A. E., & Ray, D. W. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0241 · Cited by 25
“…to those in the juvenile rat hippocampus, where dexamethasone has been shown to downregulate Bcl-2 and Bcl-xL and upregulate Bax (Sandau & Handa 2007), while downregulation of Bcl-2 expression is thought to contribute to Gc-induced apoptosis in U2-OS cells (Rogatsky et al. 1999, Lu et al. 2007).”
BackgroundBiased regulation of glucocorticoid receptors signaling
Mao, L., Wei, W., & Chen, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115145 · Cited by 30
Bridges, J. P., Schehr, A., Wang, Y., Huo, L., Besnard, V., Ikegami, M., Whitsett, J. A., & Xu, Y. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091376 · Cited by 27
Identification of microRNAs as a potential novel regulatory mechanism in HSD11B1 expression
Han, Y., Staab-Weijnitz, C. A., Xiong, G., & Maser, E. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.09.005 · Cited by 21
Robertson, S., Hapgood, J. P., & Louw, A. (2012) · Steroids · doi:10.1016/j.steroids.2012.10.016 · Cited by 27
“The glucocorticoid receptor (GR) mediates the effects of endogenous glucocorticoids (GCs) [37,49,73], as well as natural or synthetic GCs used to treat inflammatory diseases [18,24,50].”
Placental glucocorticoid receptor isoforms in a sheep model of maternal allergic asthma
Clifton, V. L., McDonald, M., Morrison, J. L., Holman, S. L., Lock, M. C., Saif, Z., Meakin, A. S., Wooldridge, A. L., Gatford, K. L., Wallace, M. J., et al. (2019) · Placenta · doi:10.1016/j.placenta.2019.06.380 · Cited by 20
Nicolaides, N. C., & Charmandari, E. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_6 · Cited by 25
Determinants of the heightened activity of glucocorticoid receptor translational isoforms
Bender, I. K., Cao, Y., & Lu, N. Z. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1009 · Cited by 19
“In addition, endogenous genes, granzyme A and caspase 6, for instance, are regulated by GR isoforms in a manner reflective of the observations made with the GRE-driven reporters (8).”
BackgroundMethodSelf-citationThe Human Glucocorticoid Receptor Beta: From Molecular Mechanisms to Clinical Implications
Nicolaides, N. C. (2022) · Endocrinology · doi:10.1210/endocr/bqac150 · Cited by 23
Molecular mechanisms of enzalutamide resistance in prostate cancer
Blatt, E. B., & Raj, G. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.25 · Cited by 26
“Upon binding its ligand, GR transcriptionally activates a stress response program, which enhances the expression of anti-inflammatory genes and suppresses pro-inflammatory genes([58-60]).”
Yao, S., Zhang, Y., Wang, X., Zhao, F., Sun, M., Zheng, X., Dong, H., & Guo, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050730 · Cited by 18
“The translational isoforms of GR could selectively regulate pro-apoptotic enzymes (Granzyme A and caspase-6) in pre-osteoblasts [24], suggesting that GR mediates GC-induced osteoblast apoptosis generally by regulating several specific genes and proteins.”
Číkoš, Š., Babeľová, J., Špirková, A., Burkuš, J., Kovaříková, V., Šefčíková, Z., Fabián, D., & Koppel, J. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy196 · Cited by 19
Endocrinology of the Stress Response During Critical Illness
Marik, P. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00076-5 · Cited by 21
Sueyoshi, T., Petrillo, M. G., Jewell, C. M., Bortner, C. D., Perera, L., Xu, X., Aguayo, F. I., Díaz-Jiménez, D., Robinson, A. G. J., Cook, M. E., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108488 · Cited by 17
“U-2OS has been used extensively to investigate glucocorticoid signaling mechanisms and has well-de fi ned glucocorticoid responses (36).”
InfluentialSelf-citationThe regulation of corticosteroid receptors in response to chronic social defeat
Zhang, J., Fan, Y., Raza, M. U., Zhan, Y., Du, X.-D., Patel, P. D., & Zhu, M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.021 · Cited by 15
“All these observations indicate that noradrenergic and serotoninergic neurons in the LC/ raphe nuclei are target cells for glucocorticoids through the GR and may reveal an association between GR activation and the transcriptive regulation of noradrenergic and serotonergic phenotypes, because activation of GR is report…”
BackgroundGlucocorticoid therapy in assisted reproduction
Kim, Y. J. (2021) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2021.04819 · Cited by 17
“tivity in a diverse manner, ranging from stimulation to suppression in a cell-specific manner [22-24].”
BackgroundLiu, Y., Jang, S., Wang, S., Chen, C.-H., & Li, F. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1074113 · Cited by 13
Ueno, K., Nomura, Y., Morita, Y., & Kawano, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640315 · Cited by 14
Marinello, W. P., Feng, L., & Allen, T. K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00900 · Cited by 14
“This is further complicated by the fact that alternative mRNA splicing and translation initiation sites leads to the generation of multiple GR isoforms (Lu and Cidlowski, 2005; Lu et al., 2007; Turner et al., 2007).”
BackgroundGlucococorticoid-Induced Death of Pancreatic Beta Cells: An Organized Chaos
Rojas, J., Chávez-Castillo, M., Chávez-Castillo, M., Cabrera, M., Cabrera, M., Bermúdez, V., & Bermúdez, V. (2015) · PubMed · doi:10.6092/1590-8577/2893 · Cited by 16
“Finally, in regards to induction of apoptosis, isoforms RGα-C and RGα-D appear to be the most and least powerful, respectively [21].”
BackgroundDuma, D., & Cidlowski, J. A. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.039 · Cited by 11
Self-citationGlucocorticoid receptor modulates dendritic cell function in ulcerative colitis.
Yang, X., Geng, J., & Meng, H. (2020) · PubMed · doi:10.14670/hh-18-241 · Cited by 19
“Different subtypes of GR have different genomic targets (Lu et al., 2007).”
Background
Metadata
- Authors
- Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A.
- Affiliations
- Molecular Endocrinology Group, Laboratory of Signal Transduction
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-10-01
- Volume
- 27
- Issue
- 20
- Pages
- 7143-7160
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2168898
- OpenAlex
- W2164942621
- Cited by
- 160
- References
- 35
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 12 · 2018: 8 · 2017: 16 · 2016: 11 · 2015: 9 · 2014: 12 · 2013: 12 · 2012: 9
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Environmental Health Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoid receptor, alternative splicing, granzyme A, caspase-6, coregulator recruitment, chromatin modification, glucocorticoid adverse effects, osteoporosis, metabolic syndrome
- MeSH terms
- Animals, Bone and Bones, Chlorocebus aethiops, Dexamethasone, Glucocorticoids, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Receptors, Glucocorticoid, Osteosarcoma, Protein Biosynthesis, Cluster Analysis, Apoptosis, COS Cells, Protein Isoforms, Caspases, Gene Expression Profiling, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.